Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

239 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Completed

Maintenance With Niraparib In Patients With Advanced Urothelial Cancer After 1st-line Platinum-based Chemotherapy

NCT03945084

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Azienda Sanitaria Locale CN2 - Alba e Bra Alba, Italy
  • Azienda USL Toscana Sud Est, Ospedale San Donato Arezzo, Italy
  • Istituto Tumori Giovanni Paolo II - IRCCS Bari, Italy
  • Presidio Ospedaliero Senatore A.Perrino Brindisi, Italy
View all 20 locations
View Trial Details
Completed

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

NCT03633110

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • John Wayne Cancer Institute - Providence Saint John's Health Center Santa Monica, California, United States
  • University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors

NCT02573259

Conditions
Carcinoma, Carcinoma, Transitional Cell, Melanoma, +21 more
Locations
  • Clinical Research Unit Los Angeles, California, United States
  • Ronald Reagan Medical Center, Department of Radiological Sciences Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
View all 67 locations
View Trial Details
Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations
  • The Angeles Clinic and Research Center Los Angeles, California, United States
  • Hackensack Medical Center Hackensack, New Jersey, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Personalized Neoantigen Cancer Vaccines

NCT03794128

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
Locations
  • University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center New York, United States
  • The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Completed

The Cxbladder Monitoring Study

NCT02700659

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Urology Center of Grove Hill, One Lake Street New Britain, Connecticut, United States
  • Florida Urology Associates Orlando, Florida, United States
  • Idaho Urologic Institute Meridian, Idaho, United States
View Trial Details

Related conditions